Novartis Seeks to Broaden Use of Some Cancer Drugs

Novartis, the Basel health-care giant, said on Wednesday that this month, it would ask regulators to clear two already marketed drugs, Tasigna and Zometa, to treat a broader range of cancers.
MarketWatch